1) As indicated above, the USA has already suggested that they’d like to get the NHS to pay more for medicines as part of a trade deal.
The UK government negotiates drug prices with the pharmaceutical industry to control costs. The US government is aiming to change this arrangement because it puts downward pressure on the revenue of American pharmaceutical companies. As outlined in the US Trade Representative’s negotiating objectives, the US will aim to use the opportunity of a potential trade deal with the UK in order to increase market access and revenues for American pharma companies.
The US Trade Representative’s Summary of Negotiating Objectives for a US-UK Trade Deal, which outlines as an objective ‘procedural fairness for pharmaceuticals and medical devices’.